Alexion Pharma (ALXN) Could Consider Buying Ra Pharmaceuticals (RARX) Outright - RBC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Ra Pharmaceuticals (RARX) Prices 8.387M Share Common Offering at $15.50/Sh
December 12, 2018 5:49 AM ESTRa Pharmaceuticals, Inc. (NASDAQ: RARX) today announced the pricing of an underwritten public offering of 8,387,097 shares of its common stock, at a public offering price of $15.50 per share, before underwriting discounts and commissions. Ra Pharma also granted the underwriters a 30-day option to... More



